Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGEF2 antisense RNA 1 (ARHGEF2-AS1)
- Target
- ARHGEF2-AS1
- Molecular classification
- Long noncoding RNA (lncRNA), Antisense RNA
01
Overview
ARHGEF2 antisense RNA 1 (ARHGEF2-AS1) is a long noncoding RNA transcribed from the ARHGEF2 locus in antisense orientation. Like other antisense RNAs, it may regulate the expression of its sense gene, ARHGEF2, or other nearby genes through cis or trans mechanisms. Antisense RNAs can interfere with transcriptional machinery, modulate chromatin structure, and alter epigenetic status, impacting gene expression at multiple levels. Most functional data on antisense RNAs derive from studies indicating they play roles in cancer, development, and immune regulation, but there is little specific published information about the exact biological and disease functions of ARHGEF2-AS1. ARHGEF2-AS1 is a noncoding RNA and not the Rho/Rac guanine nucleotide exchange factor 2 protein (ARHGEF2), which is an enzyme involved in Rho GTPase activation, innate immunity, and cancer and is considered a therapeutic protein target. While ARHGEF2-AS1 may regulate ARHGEF2, it is distinct from the protein-coding gene and its protein product.
- Other names
- ARHGEF2-AS1ARHGEF2 antisense RNA 1
02
Biological functions
Regulation of gene expression (cis/trans regulatory roles)Transcriptional interferenceEpigenetic regulationPotential involvement in chromatin modification
03
Disease associations
Cancer (general role for many antisense RNAs; specific role of ARHGEF2-AS1 in cancer is yet to be clearly established)Other (other disease roles may become evident as more specific studies on ARHGEF2-AS1 are published)
Beyond the preview
Go deeper on ARHGEF2 antisense RNA 1 (ARHGEF2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ARHGEF2 antisense RNA 1 (ARHGEF2-AS1).